Pfizer Inc.

ELREXFIO

Manufacturer:

Pfizer Inc.

Elrexfio HCPCS:

J1323

HCPCS Code Descriptor:

Injection, elranatamab-bcmm, 1 mg

Category:

J Code

Elrexfio NDCs:

00069-4494-02, 00069-2522-02

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Not Found

Route of Administration:

Subcutaneous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Elrexfio:

ELREXFIO is aligned to the J Code: J1323. ELREXFIO is an Oncology drug produced by Pfizer Inc. and administered via the Subcutaneous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J1323 Added Date:

4/1/24

J1323 Effective Date:

4/1/24

J1323 Deactive Date:

HCPCS Active

Elrexfio billing and coding information can be found through Pfizer Inc. at the link below:
Elrexfio patient assistance information can be found through Pfizer Inc. at the URL: https://www.elrexfio.com/navigating-support-financial-resources
ELREXFIO prescribing information can be found at the link below:
Information regarding ELREXFIO’s potential side effects can be found at MedlinePlus